U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H19N2.I
Molecular Weight 318.1971
Optical Activity NONE
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIMETHYLPHENYLPIPERAZINIUM IODIDE

SMILES

[I-].C[N+]1(C)CCN(CC1)C2=CC=CC=C2

InChI

InChIKey=XFZJGFIKQCCLGK-UHFFFAOYSA-M
InChI=1S/C12H19N2.HI/c1-14(2)10-8-13(9-11-14)12-6-4-3-5-7-12;/h3-7H,8-11H2,1-2H3;1H/q+1;/p-1

HIDE SMILES / InChI

Molecular Formula C12H19N2
Molecular Weight 191.2927
Charge 1
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity NONE

Molecular Formula HI
Molecular Weight 127.91241
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Dimethylphenylpiperazinium (DMPP) is an agonist of nicotinic acetylcholine receptor. DMPP regulates smooth muscle contractility. In addition, it exerts anti-inflammatory properties.

CNS Activity

Curator's Comment: Dimethylphenylpiperazinium (DMPP) is CNS active in animals. However DMPP does not easily cross the blood-brain barrier; thus, it has minimal central effects. No human data available.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Activation of neuronal SST₁ and SST₂ receptors decreases neurogenic secretion in the guinea-pig jejunum.
2010-11
Human α3β4 neuronal nicotinic receptors show different stoichiometry if they are expressed in Xenopus oocytes or mammalian HEK293 cells.
2010-10-26
Gold nanoparticle-choline complexes can block nicotinic acetylcholine receptors.
2010-05-13
Characterization of Ca2+ signaling pathways in mouse adrenal medullary chromaffin cells.
2010-03
A neuronal acetylcholine receptor regulates the balance of muscle excitation and inhibition in Caenorhabditis elegans.
2009-12
Specific subtypes of nicotinic cholinergic receptors involved in sympathetic and parasympathetic cardiovascular responses.
2009-10-02
Allosteric interaction of the anticholinergic drug [N-(4-phenyl)-phenacyl-l-hyoscyamine] (Phenthonium) with nicotinic receptors of post-ganglionic sympathetic neurons of the rat vas deferens.
2009-08-15
Expression of neuronal nicotinic acetylcholine receptors in rat vagal pulmonary sensory neurons.
2008-03-20
Beta-adrenoceptor-mediated vasodilation of retinal blood vessels is reduced in streptozotocin-induced diabetic rats.
2008-02-09
Effects of genistein and herbimycin, tyrosine kinase inhibitors, on catecholamine release in bovine adrenal chromaffin cells.
2007-10
Selective stimulation of catecholamine release from bovine adrenal chromaffin cells by an ionotropic purinergic receptor sensitive to 2-methylthio ATP.
2007-06-20
Functional distribution of Ca2+-coupled P2 purinergic receptors among adrenergic and noradrenergic bovine adrenal chromaffin cells.
2007-06-14
Muscarinic and nicotinic responses in the developing pedunculopontine nucleus (PPN).
2007-01-19
Calcium transient evoked by nicotine in isolated rat vagal pulmonary sensory neurons.
2007-01
Airway irritation and cough evoked by inhaled cigarette smoke: role of neuronal nicotinic acetylcholine receptors.
2007
The release of 3H-1-methyl-4-phenylpyridinium from bovine adrenal chromaffin cells is modulated by somatostatin.
2006-12-10
Properties of cholinergic responses in neurons in the intermediate grey layer of rat superior colliculus.
2006-12
Alpha2-adrenoceptor subtypes involved in the regulation of catecholamine release from the adrenal medulla of mice.
2006-12
Vasoactive intestinal polypeptide receptor antagonism enhances the vagally induced increase in cardiac interval of the rat atrium in vitro.
2006-05
Blockade of nicotinic receptors of bovine adrenal chromaffin cells by nanomolar concentrations of atropine.
2006-03-27
Endogenous acetylcholine enhances synchronized interneuron activity in rat neocortex.
2006-03
N-(4-Trifluoromethylphenyl)amide group of the synthetic histamine receptor agonist inhibits nicotinic acetylcholine receptor-mediated catecholamine secretion.
2006-02-28
Activation of nicotinic acetylcholine receptors increases the frequency of spontaneous GABAergic IPSCs in rat basolateral amygdala neurons.
2005-11
Modulation of airway inflammation and resistance in mice by a nicotinic receptor agonist.
2005-07
Impaired capsaicin and neurokinin-evoked colonic motility in inflammatory bowel disease.
2005-05
Selective modulation of neuronal nicotinic acetylcholine receptor channel subunits by Go-protein subunits.
2005-04-06
Nicotinic acetylcholine receptor-mediated [3H]dopamine release from hippocampus.
2005-03
Adenosine activating A(2A)-receptors coupled to adenylate cyclase/cyclic AMP pathway downregulates nicotinic autoreceptor function at the rat myenteric nerve terminals.
2004-10
Prevention of diminished parasympathetic control of the heart in experimental heart failure.
2004-10
Differential effects of FK506 and cyclosporin A on catecholamine release from bovine adrenal chromaffin cells.
2004-07
TNF-alpha hyperpolarizes membrane potential and potentiates the response to nicotinic receptor stimulation in cultured rat myenteric neurones.
2004-05
Phytoestrogen cimicifugoside-mediated inhibition of catecholamine secretion by blocking nicotinic acetylcholine receptor in bovine adrenal chromaffin cells.
2004-05
Mechanism of action of botulinum toxin on the internal anal sphincter.
2004-02
Influence of lobeline on catecholamine release from the isolated perfused rat adrenal gland.
2004-01-30
Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells.
2003-12
The effects of beta3 subunit incorporation on the pharmacology and single channel properties of oocyte-expressed human alpha3beta4 neuronal nicotinic receptors.
2003-11-07
Characterization of neuronal nicotinic acetylcholine receptors in the membrane of unmyelinated human C-fiber axons by in vitro studies.
2003-11
Regulation of epileptiform activity in hippocampus by nicotinic acetylcholine receptor activation.
2003-09
A pharmacologically distinct nicotinic ACh receptor is found in a subset of frog semicircular canal hair cells.
2003-09
SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation.
2003-07
Pharmacological characterization of recombinant bovine alpha3beta4 neuronal nicotinic receptors stably expressed in HEK 293 cells.
2003-06-12
Inhibition and facilitation by pimobendan, a calcium sensitizer, of catecholamine secretion from bovine adrenal chromaffin cells.
2003-03
Distinct protein kinases regulate SNAP-25 expression in chromaffin cells.
2003-02-01
Inhibition of acetylcholine-mediated effects by borneol.
2003-01-01
Butyl benzyl phthalate blocks Ca2+ signaling and catecholamine secretion coupled with nicotinic acetylcholine receptors in bovine adrenal chromaffin cells.
2003-01
Regulation of atrial natriuretic peptide secretion by cholinergic and PACAP neurons of the gastric antrum.
2003-01
Muscarinic and nicotinic presynaptic modulation of EPSCs in the nucleus accumbens during postnatal development.
2002-12
Fast synaptic transmission mediated by alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in lamina X neurones of neonatal rat spinal cord.
2002-11-01
Nicotinic receptors regulate the release of glycine onto lamina X neurones of the rat spinal cord.
2002-11
Nicotinic excitation of rat hypoglossal motoneurons.
2002
Patents

Patents

Sample Use Guides

guinea pig model of ovalbumin induced asthma: 0.4 and 0.8 mg/kg
Route of Administration: Intraperitoneal
In Vitro Use Guide
Incubation of cultured gastric myenteric ganglia with the nicotinic receptor agonist, 1,1-dimethyl-4-phenylpiperizinium (DMPP, 0.1 nM - 0.1 uM), for 24 h significantly increased the number of nNOS-immunoreactive cells and the density of immunoreactive nNOS bands and nNOS mRNA bands. nNOS mRNA expression stimulated by DMPP was antagonized by a protein kinase C antagonist, a phospholipase C inhibitor, and an intracellular Ca2+ chelator.
Substance Class Chemical
Created
by admin
on Mon Mar 31 20:03:40 GMT 2025
Edited
by admin
on Mon Mar 31 20:03:40 GMT 2025
Record UNII
X95H7DRX99
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-89754
Preferred Name English
DIMETHYLPHENYLPIPERAZINIUM IODIDE
Systematic Name English
DMPP IODIDE
Common Name English
PIPERAZINIUM, 1,1-DIMETHYL-4-PHENYL-, IODIDE (1:1)
Systematic Name English
N,N-DIMETHYL-N'-PHENYLPIPERAZINIUM IODIDE
Systematic Name English
1,1-DIMETHYL-4-PHENYLPIPERAZINIUM IODIDE
Systematic Name English
Code System Code Type Description
CAS
54-77-3
Created by admin on Mon Mar 31 20:03:40 GMT 2025 , Edited by admin on Mon Mar 31 20:03:40 GMT 2025
PRIMARY
NSC
89754
Created by admin on Mon Mar 31 20:03:40 GMT 2025 , Edited by admin on Mon Mar 31 20:03:40 GMT 2025
PRIMARY
ECHA (EC/EINECS)
200-213-0
Created by admin on Mon Mar 31 20:03:40 GMT 2025 , Edited by admin on Mon Mar 31 20:03:40 GMT 2025
PRIMARY
PUBCHEM
5911
Created by admin on Mon Mar 31 20:03:40 GMT 2025 , Edited by admin on Mon Mar 31 20:03:40 GMT 2025
PRIMARY
CHEBI
4290
Created by admin on Mon Mar 31 20:03:40 GMT 2025 , Edited by admin on Mon Mar 31 20:03:40 GMT 2025
PRIMARY
FDA UNII
X95H7DRX99
Created by admin on Mon Mar 31 20:03:40 GMT 2025 , Edited by admin on Mon Mar 31 20:03:40 GMT 2025
PRIMARY
MESH
D004246
Created by admin on Mon Mar 31 20:03:40 GMT 2025 , Edited by admin on Mon Mar 31 20:03:40 GMT 2025
PRIMARY
EPA CompTox
DTXSID90968822
Created by admin on Mon Mar 31 20:03:40 GMT 2025 , Edited by admin on Mon Mar 31 20:03:40 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE